Insights into HIV-specific immune function: implications for therapy and prevention in the new millennium.
Moss
R B
RB
The Immune Response Corporation, Carlsbad, California 92008, USA.
Jensen
F C
FC
Carlo
D J
DJ
D000918:Antibody Specificity; D000998:Antiviral Agents / Q000494:pharmacology; D015496:CD4-Positive T-Lymphocytes / Q000502:physiology; D018414:CD8-Positive T-Lymphocytes / Q000502:physiology; D006678:HIV / Q000276:immunology*; D015658:HIV Infections / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D007111:Immunity, Cellular; D014779:Virus Replication / Q000276:immunology / Q000502:physiology
D000998:Antiviral Agents